PL2419132T3 - Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa - Google Patents

Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa

Info

Publication number
PL2419132T3
PL2419132T3 PL10713677T PL10713677T PL2419132T3 PL 2419132 T3 PL2419132 T3 PL 2419132T3 PL 10713677 T PL10713677 T PL 10713677T PL 10713677 T PL10713677 T PL 10713677T PL 2419132 T3 PL2419132 T3 PL 2419132T3
Authority
PL
Poland
Prior art keywords
immunizing
vaccine
herpes virus
virus vectors
recombinant avian
Prior art date
Application number
PL10713677T
Other languages
English (en)
Inventor
Yannick Gardin
Vilmos Palya
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of PL2419132T3 publication Critical patent/PL2419132T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL10713677T 2009-04-15 2010-04-15 Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa PL2419132T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16945909P 2009-04-15 2009-04-15
US21828009P 2009-06-18 2009-06-18
US22697009P 2009-07-20 2009-07-20
EP10713677.2A EP2419132B1 (en) 2009-04-15 2010-04-15 Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
PCT/EP2010/054991 WO2010119112A1 (en) 2009-04-15 2010-04-15 Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species

Publications (1)

Publication Number Publication Date
PL2419132T3 true PL2419132T3 (pl) 2015-03-31

Family

ID=42314196

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10713677T PL2419132T3 (pl) 2009-04-15 2010-04-15 Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa

Country Status (4)

Country Link
EP (1) EP2419132B1 (pl)
CN (2) CN102405058B (pl)
PL (1) PL2419132T3 (pl)
WO (1) WO2010119112A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103370079B (zh) 2010-10-18 2016-08-10 英特维特国际股份有限公司 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗
CN102154224A (zh) * 2010-12-14 2011-08-17 山东农业大学 一株重组鸡马立克氏病疫苗病毒sc9-1株的构建和应用
CN102323428B (zh) * 2011-08-17 2014-02-26 湖北省农业科学院畜牧兽医研究所 鸭疫里默氏杆菌抗体间接elisa方法检测试剂盒及其应用
BR112014009565A2 (pt) 2011-10-21 2017-04-18 Intervet Int Bv vírus da doença de marek não patogênico recombinante, ácido nucleico recombinante, vacina, e, método para ajudar na proteção de um frango contra vírus
SI2785373T1 (sl) * 2011-11-30 2020-02-28 Boehringer Ingelheim Animal Health USA Inc. Rekombinantni vektorji HVT, ki izražajo antigene aviarnih patogenov in uporabe le-teh
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN103667351B (zh) * 2012-09-10 2017-01-25 中国农业科学院哈尔滨兽医研究所 以鸭病毒性肠炎病毒疫苗株为载体的重组病毒疫苗在鸡形目禽类中的应用
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
CN102895660B (zh) * 2012-10-25 2014-04-23 中国兽医药品监察所 一种鸭病毒性肝炎二价灭活疫苗
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
CN103495160B (zh) * 2013-10-08 2015-11-18 南京天邦生物科技有限公司 鸡滑液囊支原体灭活疫苗的制备方法
CN104195116B (zh) * 2014-08-13 2018-03-06 吉林大学 一种表达鹅细小病毒vp3基因的重组新城疫病毒及其构建方法
EP3050572A1 (en) * 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
CN105821010B (zh) * 2016-05-11 2019-12-24 江苏康缘瑞翱生物医药科技有限公司 一种表达鸡ibdv抗体的重组ndv及其在制备双价疫苗中的应用
CN106350475A (zh) * 2016-08-26 2017-01-25 江苏省农业科学院 一种新型火鸡疱疹病毒的细菌人工染色体、构建方法与应用
CN108324937A (zh) * 2018-01-17 2018-07-27 华中农业大学 表达禽腺病毒血清4型五邻体蛋白的火鸡疱疹病毒活载体疫苗及其制备和应用
CN109136264B (zh) * 2018-09-19 2022-07-29 天康制药(苏州)有限公司 马疱疹病毒1型gB-gD融合蛋白、重组载体和真核细胞株及其制备方法和疫苗
PE20220232A1 (es) * 2018-12-21 2022-02-07 Ceva Sante Animale Virus del herpes aviar recombinantes que contienen multiples genes extranos
CN110791479B (zh) * 2019-07-27 2023-04-21 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） DEV gB蛋白单抗以及检测DEV抗体的阻断ELISA试剂盒
CN111000992A (zh) * 2019-12-19 2020-04-14 广州渔跃生物技术有限公司 一种鸭呼肠孤病毒、鸭坦布苏病毒和鸭腺病毒三联灭活疫苗及其制备方法
CN111000993B (zh) * 2020-01-07 2022-08-23 齐鲁动物保健品有限公司 一种鸭病毒性肝炎、鸭呼肠孤病毒病二联灭活疫苗及其制备方法
CN111569059B (zh) * 2020-05-28 2023-11-14 四川格瑞帝夫科技有限公司 一种禽类用抗原-抗体复相疫苗及制备方法
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗
CN113384692A (zh) * 2020-12-28 2021-09-14 哈药集团生物疫苗有限公司 鸭呼肠弧病毒、鸭圆环病毒二联灭活疫苗及其制备方法
CN114209821A (zh) * 2021-12-30 2022-03-22 哈药集团生物疫苗有限公司 防治鸭圆环病毒病、新型鸭呼肠孤病毒病和鸭腺病毒病3型的三联灭活疫苗及其制备方法
CN116042709A (zh) * 2022-09-23 2023-05-02 广西大学 一种共表达马立克病病毒糖蛋白gC和gD的DNA疫苗构建方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2796287B2 (ja) 1985-05-30 1998-09-10 コモンウエルス サイエンテイフイツク アンド インダストリアル リサ−チ オ−ガナイゼイシヨン Ｉｂｄｖの宿主保護性免疫原のクローニング及び発現
US5928648A (en) 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
EP0658623A3 (en) 1987-07-27 1995-09-27 Syntro Corp Attenuated herpes viruses, herpes viruses that contain foreign DNA encoding an amino acid sequence, and vaccines containing them.
JPH06292583A (ja) 1992-03-17 1994-10-21 Nippon Zeon Co Ltd マレック病ウイルス由来の抗原タンパク質、その遺伝子組み換え体、及びそれを用いたワクチン
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
DE69738977D1 (de) 1996-03-29 2008-10-23 Zeon Corp Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung
US6632664B1 (en) 1997-10-03 2003-10-14 Nippon Zeon Co., Ltd. Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
WO2001005988A1 (en) * 1999-07-16 2001-01-25 Merial Select, Inc Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
US6936707B2 (en) 2001-07-11 2005-08-30 Zeon Corporation Modified DNA molecule, recombinant containing the same, and uses thereof
US6866852B2 (en) 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes

Also Published As

Publication number Publication date
CN102405058A (zh) 2012-04-04
CN105567648B (zh) 2019-09-03
EP2419132A1 (en) 2012-02-22
WO2010119112A1 (en) 2010-10-21
EP2419132B1 (en) 2014-06-25
CN102405058B (zh) 2015-11-25
CN105567648A (zh) 2016-05-11

Similar Documents

Publication Publication Date Title
PL2419132T3 (pl) Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa
ZA201406979B (en) Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
EP2632485A4 (en) RECOMBINANT SUBUNIT VACCINE AGAINST DENGUE VIRUS
IL248607A (en) Methods and preparations for vaccination against virus
GB2592769B (en) CpG-Adjuvanted SARS-CoV-2 virus vaccine
ZA201006437B (en) Replication-defective flavivirus vaccines and vaccine vectors
ZA201206619B (en) Bluetongue virus recombinant vaccines and uses thereof
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
IL229307A0 (en) Inactivated dengue virus vaccine
PL2629794T3 (pl) Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu
IL214385A (en) Inactive dengue virus vaccine with aluminum-free assists
EP2631290A4 (en) VIRUS VECTOR FOR PRIME-BOOST VACCINES WITH VACCINIAVIRUS VECTORS AND SENDAIVIRUS VECTORS
LT2547364T (lt) Peptidai, konjugatai ir vakcinos imunogeniškumo padidinimo būdas
EP2486791A4 (en) PROTEIN VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS FROM TRANSGENIC PLANTS AND PREPARATION METHOD THEREOF
PT2658570T (pt) Composições e métodos vacinais contra o vírus da diarreia viral bovina tipo 1b
EP2438198A4 (en) COMPOSITIONS AND METHODS FOR THE DELIVERY OF VACCINES AGAINST DENGUE VIRUS
HRP20181439T1 (hr) Cjepivo protiv modificiranog virusa sendai i vizualizacijski vektor
HK1212358A1 (en) Grass peptides for vaccine
ZA201104013B (en) Recombinant inactivated viral vector vaccine
ZA201103031B (en) Vaccine against african horse sickness virus
GB0917871D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB0902344D0 (en) Peptides for vaccine